Etienne Chatelut

Toulouse, 31059, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.

Journal: Cancers
Published: February 26, 2026

Does Next Generation Sequencing (NGS)-Based CYP2D6 Sequencing Improve Genotype-Phenotype Concordance in Tamoxifen-Treated Patients?

Does Next Generation Sequencing (NGS)-Based CYP2D6 Sequencing Improve Genotype-Phenotype Concordance in Tamoxifen-Treated Patients?

Journal: Clinical pharmacology and therapeutics
Published: February 12, 2026

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.

Journal: British journal of cancer
Published: January 20, 2026

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

Journal: NPJ breast cancer
Published: December 03, 2025

Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokinetics.

Model-based meta-analysis of individual patient data for the characterization of intravenous 5-fluorouracil population pharmacokinetics.

Journal: Cancer chemotherapy and pharmacology
Published: November 28, 2025

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Journal: Cancers
Published: November 26, 2025

Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods.

Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods.

Journal: Clinical pharmacokinetics
Published: October 29, 2025

Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy.

Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy.

Journal: Cancer chemotherapy and pharmacology
Published: September 22, 2025

Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium.

Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortium.

Journal: Therapie
Published: August 04, 2025

Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.

Journal: Cancer chemotherapy and pharmacology
Published: July 25, 2025

A population pharmacokinetic approach to compare 51Cr-EDTA and 99 mTc-DTPA clearances in measuring renal glomerular filtration rate in oncopediatrics.

A population pharmacokinetic approach to compare 51Cr-EDTA and 99 mTc-DTPA clearances in measuring renal glomerular filtration rate in oncopediatrics.

Journal: Pediatric nephrology (Berlin, Germany)
Published: February 24, 2025

Reply to: "Is uracil enough for effective pre-emptive DPD testing?"

Reply to: "Is uracil enough for effective pre-emptive DPD testing?"

Journal: Clinical chemistry and laboratory medicine
Published: August 02, 2024
Showing 1-12 of 121

Last Updated: 09/26/2026